Hepatitis B Immune Globulin Intravenous (Human)

CHEBI:CHEBI_749367

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1658423
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
dosage_form
INJECTION
route
INTRAVENOUS
marketing_start_date
20190301
package_marketing_start_date
20190301
marketing_category
BLA
pharm_class
Human Immunoglobulin [EPC]
pharm_class_cs
Immunoglobulins [CS]
pharm_class_pe
Passively Acquired Immunity [PE]
nui
N0000184164
pharm_class_moa
Virus Neutralization [MoA]
generic_name
Hepatitis B Immune Globulin Intravenous (Human)
brand_name
HepaGam B
brand_name_base
HepaGam B
product_ndc
70257-052
application_number
BLA125035
labeler_name
Saol Therapeutics Inc.
manufacturer_name
Saol Therapeutics Inc.
spl_id
239012ee-5f14-4aed-9b1d-4e3e3283406f
active_ingredient_name
HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
active_ingredient_strength
312 [iU]/mL
package_ndc
70257-052-51
package_description
1 VIAL, GLASS in 1 CARTON (70257-052-51) / 1 mL in 1 VIAL, GLASS (70257-052-11)
unii
XII270YC6M
spl_set_id
2ba8df27-4f35-41f6-8148-0c213c18df4e
pharm_class_epc
Human Immunoglobulin [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class